GHIT Fund Global Health Innovative Technology Fund

We seek out R&D solutions to health where others don’t

We catalyze creative partnerships across different sectors and cultures

We believe medicine is invaluable with access, valueless without it

Health is a right, not an option

Scroll
Annual Report 2019
GHIT Brand Film
Strategic Plan 2018 - 2022

The Japan-based GHIT Fund is an international public-private partnership fund for global health R&D
that mobilizes Japanese industry, academia, and research institutes to create new drugs, vaccines, and diagnostics
for malaria, tuberculosis, and neglected tropical diseases, in collaboration with global partners.

LATEST NEWS

September 29, 2020 | Press Release

GHIT Fund Announces New Investments: A Total of 1.37 Billion Yen in Drugs for…

September 14, 2020 | Films

Film: GHIT Fund Proposal Writing Seminar (English ver / at GHIT R&D Forum)

September 1, 2020 | News

New investment opportunity for Screening Platform

August 11, 2020 | Films

Film: GHIT Fund Proposal Writing Seminar (Japanese Language Only)

July 3, 2020 | News

Uniting Efforts published a new report entitled "Landscape of funding and fin…

June 30, 2020 | Publications

GHIT’s 2019 Annual Report Published
Newsroom

Why Global
Health R&D

Japan's Science and Pharmaceutical Capabilities for Global Health

Business
Model

World’s First Public-Private Partnership Fund for Global Health R&D

Investment
Opportunities

R&D Platforms and RFP Schedule

Investment to Date
since 2013

USD223M
Total Investment
94
Total Invested
Partnerships
137
Total Product
Development Partners
8
Clinical Trials

・Twitter